Nachrichten zur Abbvie Inc. Aktie

AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast…

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped…

Abbvie Inc (NYSE:ABBV) shares moved higher after it reported strong results for the first quarter of 2025 and raised its full-year…

AbbVie-Aktie legt zu, doch Experten bewerten unterschiedlich. Neue Medikamente sollen Humira-Verluste ausgleichen. Bleibt die Erwartungshaltung realistisch? Analysten gespaltenAnzeigeSollten Anlege...…

The medical sector can provide a defensive hedge against economic uncertainty, and investors may be eyeing AbbVie (ABBV) and HCA…

Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…

Investors will likely focus on the sales performance of AbbVies blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports Q1…

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

In the closing of the recent trading day, AbbVie (ABBV) stood at $170.16, denoting a -1.64% change from the preceding…

Lets say you have $500 to invest and youre wondering where to park it. Thats a great position to be…

AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX)…

Merck and AbbVie are included in this Analyst Blog.…

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Income investors could pay attention to the price fluctuations of the assets they own. But they dont have to. What…

Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.…

As of Mondays close, the S&P 500 has fallen by about 15% this year (although the index regained about half…

These are the stocks posting the largest moves in midday trading.…

With equity markets in shambles due to President Donald Trumps trade policies, now might be as good a time as…

From TV star to powerful government official. Thats the path taken by President Donald Trump and his new administrator of…

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex…

What should investors do when stocks are tanking over the short term? Probably the best answer is to think long…

One factor that keeps some investors away from healthcare stocks is the sectors dearth of generous and reliable dividend payers.…

In the closing of the recent trading day, AbbVie (ABBV) stood at $201.64, denoting a -1.73% change from the preceding…

AbbVie cuts 2025 profit forecast on acquisition expenses…

AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses.…

"Buy and hold" is a simple strategy for investors, but it can be a hard one to stick to in…

Those who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks…

Basel, March 31, 2025 – Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal…

Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo…

The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.…